Description

Evolocumab is a monoclonal antibody used to lower cholesterol levels in patients with hyperlipidemia. It works by inhibiting PCSK9, a protein that leads to increased LDL cholesterol levels in the blood. This medication is typically prescribed for patients who have not achieved adequate cholesterol control with statins alone.

Interpreter Notes

Interpreters should be aware that the term 'Evolocumab' may be accompanied by various brand names, such as Repatha, which could be used interchangeably in clinical settings. It is important to maintain a formal register and avoid colloquial expressions. Stick to the glossary term in formal contexts to ensure clarity.

Example Sentences

EN: Evolocumab has been shown to significantly reduce LDL cholesterol levels in clinical trials.

ES: Evolocumab ha demostrado reducir significativamente los niveles de colesterol LDL en ensayos clínicos.

Common Interpreter Mistakes

Confusing Evolocumab with similar-sounding medications; mispronouncing Evolocumab; mixing up with other lipid-lowering agents.